Candriam SCA’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-228,562
Closed -$20.4M 732
2017
Q1
$20.4M Sell
228,562
-261,481
-53% -$21.5M 0.39% 54
2016
Q4
$34.7M Buy
490,043
+103,951
+27% +$7.75M 0.8% 19
2016
Q3
$30.5M Buy
386,092
+70,110
+22% +$5.98M 0.73% 24
2016
Q2
$28.7M Buy
315,982
+581
+0.2% +$49.2K 0.75% 27
2016
Q1
$26.7M Buy
315,401
+298,938
+1,816% +$22.2M 0.67% 31
2015
Q4
$1.3M Sell
16,463
-60,450
-79% -$4.76M 0.03% 355
2015
Q3
$5.42M Sell
76,913
-7,368
-9% -$606K 0.13% 189
2015
Q2
$7.6M Sell
84,281
-68,417
-45% -$6.6M 0.16% 177
2015
Q1
$15.4M Sell
152,698
-152,942
-50% -$15.4M 0.31% 80
2014
Q4
$30.7M Buy
+305,640
New +$30.5M 0.64% 35

Other funds holding MJN

Candriam SCA's MJN Position: Q2 2017 in Review

Candriam SCA sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 228,562 shares — an estimated $20.4M sold.

Candriam SCA first reported a position in MJN in Q4 2014 and held it in 10 quarters. The position peaked at $34.7M in Q4 2016. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Candriam SCA reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Candriam SCA sold 228,562 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $20.4M.
  • Candriam SCA first reported a position in Mead Johnson Nutrition Company in Q4 2014 and held it in 10 quarters.
  • Candriam SCA's Mead Johnson Nutrition Company position peaked at $34.7M in Q4 2016.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Candriam SCA's 13F filing for Q2 2017, filed 31 Jul 2017.